Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections - Contacts and Locations

Home

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

This study has been completed.

Study NCT00417573. Last updated on December 29, 2006. Information provided by The Center for Rheumatic Disease, Allergy, & Immunology

Please refer to this study by its ClinicalTrials.gov identifier: NCT00417573

Locations


United States, Missouri
	Center for Rheumatic Disease, Allergy, Immunology
	Kansas City, Missouri, United States, 64111

Sponsors and Collaborators

The Center for Rheumatic Disease, Allergy, & Immunology

Talecris Biotherapeutics

Investigators


Principal Investigator:	Nabih I Abdou, MD, PhD	Center for Rheumatic Disease, Allergy, Immunology